Closeout Bridging Administrative Supplement to R01AG049611
R01AG049611 的清仓桥接管理补充
基本信息
- 批准号:10281452
- 负责人:
- 金额:$ 35.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAcuteAdministrative SupplementAdverse eventAgingAmino Acid TransporterAmino AcidsAnabolismAwardBed restBudgetsCOVID-19 pandemicChronicClinicalClinical ResearchComplexDataDevelopmentDirect CostsElderlyEquilibriumEventExerciseFRAP1 geneFire - disastersFloodsFundingGrantHealthHospitalizationHospitalsHousingHuman ResourcesHurricaneInpatientsInterventionKnowledgeLifeMissionMuscle ProteinsMuscular AtrophyNon-Insulin-Dependent Diabetes MellitusParentsPatient CarePhysical FunctionProtein BiosynthesisPublic HealthReportingResearchResearch ActivityResearch Project GrantsResearch SubjectsResistanceSamplingSignal TransductionSkeletal MuscleSocietiesStimulusSuspensionsTransportationUnited States National Institutes of HealthWagesWorkbasecare costscostdietarydisabilitydisability burdenexperimental studyextracellularimprovedinnovationlaboratory experimentparent grantpreventrecruitresistance exercisesarcopenia
项目摘要
PROJECT SUMMARY
This administrative supplement for closeout bridge funding is requested to complete the research activities of
the parent R01 grant after the end of the grant period. The parent award has suffered three major delays due
to catastrophic events we have suffered over the past four years, which have slowed down subject recruitment
and completion of the planned aims: 1) a hospital fire in 2017 which produced a 3 month delay; 2) flooding
from Hurricane Harvey in 2017, which resulted in another major delay in grant-related activities due to
destruction brought by the flood to personnel and research subjects' housing and transportation and
dramatically reduced recruitment pace well into the Winter 2017-2018; 3) the COVID-19 Pandemic 2020, which
caused another 5-month delay. Overall, these three devastating events add up to an approximately 1-year
delay in parent grant study activities. During the three events we were able to save budget for supplies and
patient care costs, but we were unable to save personnel costs. This closeout bridging administrative
supplement will allow us to complete the planned studies during the no-cost extension year of the parent grant
with no change to its scope. The parent grant objective is to examine the basic mechanisms that underlie
accelerated sarcopenia in older adults and identify potential targets for interventions. The central hypothesis,
based on our preliminary data, is that a global and fundamental mechanism of acute or chronic acceleration of
sarcopenia is a reduction in skeletal muscle amino acid transport, which decreases muscle protein anabolism,
and can be reversed by activation of the mammalian/mechanistic Target of Rapamycin Complex 1 (mTORC1)
signaling with a non- amino acid stimulus such as exercise. The aims are: 1) Determine the effect of T2DM on
the sensitivity of skeletal muscle amino acid transport to dietary amino acids. 2) Determine the effect of short-
term bed rest inactivity on the sensitivity of skeletal muscle amino acid transport to dietary amino acids. 3)
Determine the effect of resistance exercise on the sensitivity of amino acid transport to dietary amino acids in
acute and chronic accelerated sarcopenia induced by inactivity and T2DM.
项目摘要
本行政补充收尾桥梁资金要求完成的研究活动,
在授权时段结束之后的父R 01授权。父母奖已经遭受了三次重大延误,
我们在过去四年中遭受的灾难性事件,这些事件减缓了受试者招募
并完成了计划目标:1)2017年的一场医院火灾,造成3个月的延误; 2)洪水
2017年哈维飓风导致赠款相关活动再次出现重大延误,
洪水对人员和研究对象的住房和交通造成的破坏,
2017-2018年冬季大幅降低招聘速度; 3)2020年COVID-19大流行,
又拖延了5个月。总的来说,这三次灾难性事件加起来大约需要1年的时间。
家长补助研究活动延迟。在这三个活动中,我们能够节省供应预算,
病人护理费用,但我们无法节省人力成本。这次收尾工作将行政
补助金将使我们能够在父母补助金的免费延长年度内完成计划中的研究
其范围没有变化。家长补助金的目标是研究基本机制,
加速老年人的肌肉减少症,并确定潜在的干预目标。中心假设,
根据我们的初步数据,急性或慢性加速的全球性和基本机制是否
肌肉减少症是骨骼肌氨基酸转运的减少,这降低了肌肉蛋白质的亲和力,
并且可以通过激活哺乳动物/雷帕霉素复合物1的机制靶(mTORC 1)来逆转
用非氨基酸刺激物如运动进行信号传导。目的是:1)确定T2 DM对
骨骼肌氨基酸转运对膳食氨基酸的敏感性。2)确定短-
长期卧床不活动对骨骼肌氨基酸转运对膳食氨基酸敏感性的影响。第三章
确定抗阻运动对氨基酸转运对膳食氨基酸的敏感性的影响,
由不活动和T2 DM引起的急性和慢性加速性肌肉减少症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elena Volpi其他文献
Elena Volpi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elena Volpi', 18)}}的其他基金
Identifying therapeutic targets of accelerated sarcopenia
确定加速肌少症的治疗靶点
- 批准号:
9056065 - 财政年份:2016
- 资助金额:
$ 35.59万 - 项目类别:
NUTRITION & EXERCISE TO IMPROVE PROTEIN METABOLISM & PREVENT SARCOPENIA IN AGING
营养
- 批准号:
7952172 - 财政年份:2009
- 资助金额:
$ 35.59万 - 项目类别:
CLINICAL TRIAL: INSULIN AND SARCOPENIA IN THE ELDERLY (CYCLE NO, 2)
临床试验:老年人的胰岛素和肌肉减少症(第 2 周期)
- 批准号:
7952154 - 财政年份:2009
- 资助金额:
$ 35.59万 - 项目类别:
CLINICAL TRIAL: NUTRITIONAL INTERVENTIONS FOR MAXIMAL MUSCLE GAIN IN MIDDLE-AGED
临床试验:中年人最大肌肉增长的营养干预
- 批准号:
7952163 - 财政年份:2009
- 资助金额:
$ 35.59万 - 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
- 批准号:
8073013 - 财政年份:2008
- 资助金额:
$ 35.59万 - 项目类别:
CLINICAL TRIAL: NUTRITIONAL INTERVENTIONS FOR MAXIMAL MUSCLE GAIN IN MIDDLE-AGED
临床试验:中年人最大肌肉增长的营养干预
- 批准号:
7719200 - 财政年份:2008
- 资助金额:
$ 35.59万 - 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
- 批准号:
8141802 - 财政年份:2008
- 资助金额:
$ 35.59万 - 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
- 批准号:
8277275 - 财政年份:2008
- 资助金额:
$ 35.59万 - 项目类别:
CLINICAL TRIAL: INSULIN AND SARCOPENIA IN THE ELDERLY (CYCLE NO, 2)
临床试验:老年人的胰岛素和肌肉减少症(第 2 周期)
- 批准号:
7719189 - 财政年份:2008
- 资助金额:
$ 35.59万 - 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
- 批准号:
7844855 - 财政年份:2008
- 资助金额:
$ 35.59万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 35.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 35.59万 - 项目类别:
Operating Grants














{{item.name}}会员




